Drugs / low molecule heparin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04256525 | May 2020 → Aug 2021 | venous thromboembolism | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | low molecule heparin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04256525 ↗ |
| Route | Subcutaneous | “0.4ml per day subcutaneous injection” NCT04256525 ↗ |